GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IMRIS Inc (GREY:IMRSQ) » Definitions » Debt-to-Equity

IMRIS (IMRSQ) Debt-to-Equity : 1.99 (As of Dec. 2014)


View and export this data going back to 2010. Start your Free Trial

What is IMRIS Debt-to-Equity?

IMRIS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2014 was $2.46 Mil. IMRIS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2014 was $21.03 Mil. IMRIS's Total Stockholders Equity for the quarter that ended in Dec. 2014 was $11.79 Mil. IMRIS's debt to equity for the quarter that ended in Dec. 2014 was 1.99.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for IMRIS's Debt-to-Equity or its related term are showing as below:

IMRSQ's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.21
* Ranked among companies with meaningful Debt-to-Equity only.

IMRIS Debt-to-Equity Historical Data

The historical data trend for IMRIS's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMRIS Debt-to-Equity Chart

IMRIS Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only - - - 0.61 1.99

IMRIS Quarterly Data
Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.61 0.80 1.12 1.58 1.99

Competitive Comparison of IMRIS's Debt-to-Equity

For the Medical Devices subindustry, IMRIS's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMRIS's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IMRIS's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where IMRIS's Debt-to-Equity falls into.



IMRIS Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

IMRIS's Debt to Equity Ratio for the fiscal year that ended in Dec. 2014 is calculated as

IMRIS's Debt to Equity Ratio for the quarter that ended in Dec. 2014 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMRIS  (GREY:IMRSQ) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


IMRIS Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of IMRIS's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


IMRIS (IMRSQ) Business Description

Traded in Other Exchanges
N/A
Address
100-1370 Sony Place, Winnipeg, MB, CAN, R3T 1N5
IMRIS Inc designs, manufactures and markets Image-guided therapy systems that improves the effectiveness of therapy delivery. Its main product is the Visius surgical theater. The company provides its products to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. The firm is focused on bringing enhanced visualization to the point of therapy delivery and is spread across Canada, United States, Europe and the Middle East and Asia-Pacific.

IMRIS (IMRSQ) Headlines

No Headlines